Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2025-12-26 @ 10:18 PM
NCT ID: NCT00567112
Description: None
Frequency Threshold: 5
Time Frame: From first dose of study drug administration through to 72 hours post-administration
Study: NCT00567112
Study Brief: Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
OCT (Fasted) Participants receiving a single dose of 10 mg MK-0941 OCT administered in a fasted state None None 0 18 6 18 View
OCT (After Meal) Participants receiving a single dose of 10 mg MK-0941 OCT administered after consumption of a high-fat meal None None 0 17 7 17 View
OCT (Before Meal) Participants receiving a single dose of 10 mg MK-0941 OCT administered before consumption of a standard breakfast None None 0 14 3 14 View
DFC (Fasted) Participants receiving a single dose of 10 mg MK-0941 DFC administered in a fasted state None None 0 15 4 15 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.0) View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.0) View
Catheter site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.0) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (11.0) View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (11.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (11.0) View
Hypoglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (11.0) View
Infusion site erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.0) View
Infusion site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.0) View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.0) View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (11.0) View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.0) View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (11.0) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (11.0) View
Tongue Blistering SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.0) View